Location
Canada, North America
Cheque size
$100K - $5M
Investment Stage
Series A
Focus Areas
Health IT
Health & Hospital Services
BioTech
Medical Devices
About Investor
Jerel Davis is a managing director at Versant Ventures. He focuses on biotech and consumer health at Seed and Series A, with an investment range of $100K - $5.0M. Since joining Versant in 2011, he has helped launch and support more than 25 portfolio companies and has centered his investing on company creation, early syndication, and innovative pharma partnerships. Before joining the firm, he advised global pharmaceutical and biotech companies at McKinsey and trained as a scientist at Amgen.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,AL
Alicia Lenis
Canada, North America
$500K - $2M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.